References
- Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 2006;7(3):241–248. doi: 10.1016/S1470-2045(06)70615-5.
- Jalali R, Raut N, Arora B, et al. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys. 2010;77(1):113–118. doi: 10.1016/j.ijrobp.2009.04.031.
- Lassaletta A, Strother D, Laperriere N, et al. Reirradiation in patients with diffuse intrinsic pontine gliomas: the Canadian experience. Pediatr Blood Cancer. 2018;65(6):e26988. doi: 10.1002/pbc.26988.
- Massimino M, Biassoni V, Miceli R, et al. Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood. J Neurooncol. 2014;118(2):305–312. doi: 10.1007/s11060-014-1428-z.
- Janssens GO, Gandola L, Bolle S, et al. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. Eur J Cancer. 2017;73:38–47. doi: 10.1016/j.ejca.2016.12.007.
- Krishnatry R, Manjali JJ, Chinnaswamy G, et al. Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma. Jpn J Clin Oncol. 2021;51(5):762–768. doi: 10.1093/jjco/hyab006.
- Andratschke N, Willmann J, Appelt AL, et al. European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus on re-irradiation: definition, reporting, and clinical decision making. Lancet Oncol. 2022;23(10):e469–e478. doi: 10.1016/S1470-2045(22)00447-8.
- DNOG. Nationale retningslinjer for proton behandling. 2022.
- DNOG. DNOG Retningslinjer for strålebehandling. 2016.
- Daniel Wollschlaeger and Heiko Karle "DVH metrics. RStudio". Germany: University Medical Center Mainz; 2022.
- Joiner MC, van der Kogel A. Basic clinical radiobiology. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2009.
- Jiang P, Zhang X, Jiang W, et al. Analysis of long-term outcome of image-guided volumetric modulated arc therapy (VMAT) for primary malignant tumor of the cervical spine. Cancer Biol Ther. 2020;21(7):623–628. doi: 10.1080/15384047.2020.1743149.
- Mayo C, Martel MK, Marks LB, et al. Radiation dose–volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S28–S35. doi: 10.1016/j.ijrobp.2009.07.1753.
- Mayo C, Yorke E, Merchant TE. Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S36–S41. doi: 10.1016/j.ijrobp.2009.08.078.
- Darzy KH, Shalet SM. Hypopituitarism following radiotherapy. Pituitary. 2009;12(1):40–50. doi: 10.1007/s11102-008-0088-4.
- Chan SH, Ng WT, Kam KL, et al. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Int J Radiat Oncol Biol Phys. 2009;73(5):1335–1342. doi: 10.1016/j.ijrobp.2008.07.034.
- Jeganathan VSE, Wirth A, MacManus MP. Ocular risks from orbital and periorbital radiation therapy: a critical review. Int J Radiat Oncol Biol Phys. 2011;79(3):650–659. doi: 10.1016/j.ijrobp.2010.09.056.
- Fontanilla HP, Pinnix CC, Ketonen LM, et al. Palliative reirradiation for progressive diffuse intrinsic pontine glioma. Am J Clin Oncol. 2012;35(1):51–57. doi: 10.1097/COC.0b013e318201a2b7.
- Amsbaugh MJ, Mahajan A, Thall PF, et al. A phase 1/2 trial of reirradiation for diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys. 2019;104(1):144–148. doi: 10.1016/j.ijrobp.2018.12.043.
- Freese C, Takiar V, Fouladi M, et al. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature. Pract Radiat Oncol. 2017;7(2):86–92. doi: 10.1016/j.prro.2016.11.005.
- Stiefel I, Schröder C, Tanadini-Lang S, et al. High-dose re-irradiation of intracranial lesions – efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose calculation. Clin Transl Radiat Oncol. 2021;27:132–138. doi: 10.1016/j.ctro.2021.01.011.
- Tsang DS, Burghen E, Klimo P, et al. Outcomes after reirradiation for recurrent pediatric intracranial ependymoma. Int J Radiat Oncol Biol Phys. 2018;100(2):507–515. doi: 10.1016/j.ijrobp.2017.10.002.
- Lu VM, Welby JP, Mahajan A, et al. Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis. Childs Nerv Syst. 2019;35(5):739–746. doi: 10.1007/s00381-019-04118-y.
- Madrid AL, Santa-Maria V, Martinez OC, et al. Hg-37second re-irradiation for DIPG progression, re-considering “old strategies” with new approaches. Neuro Oncol. 2016;18(suppl 3):iii55.4–iii56. doi: 10.1093/neuonc/now073.34.
- Bergengruen PM, Hernaíz Driever P, Budach V, et al. Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma. Strahlenther Onkol. 2023;199(8):773–777. doi: 10.1007/s00066-023-02057-x.
- Vanan MI, Eisenstat DD. DIPG in children – what can we learn from the past? Front Oncol. 2015;5:237. doi: 10.3389/fonc.2015.00237.
- Hayashi A, Ito E, Omura M, et al. Hypofractionated radiotherapy in children with diffuse intrinsic pontine glioma. Pediatr Int. 2020;62(1):47–51. doi: 10.1111/ped.14070.
- Zamora PL, Miller SR, Kovoor JJ. Single institution experience in re-irradiation of biopsy-proven diffuse intrinsic pontine gliomas. Childs Nerv Syst. 2021;37(8):2539–2543. doi: 10.1007/s00381-021-05195-8.